PPP1R12A and breast carcinoma: Combined with the present results using MDA-MB-231 cells, the active “ATP8A1-PS-YAP phosphatase (PPP1R12A/PP1B)” axis may account for the poor prognosis of breast cancer patients through YAP activation.